These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25911336)

  • 1. EASL Recommendations on Treatment of Hepatitis C 2015.
    European Association for Study of Liver
    J Hepatol; 2015 Jul; 63(1):199-236. PubMed ID: 25911336
    [No Abstract]   [Full Text] [Related]  

  • 2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2011 Aug; 55(2):245-64. PubMed ID: 21371579
    [No Abstract]   [Full Text] [Related]  

  • 3. [Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection].
    Rao HY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):391-4. PubMed ID: 21972444
    [No Abstract]   [Full Text] [Related]  

  • 4. EASL Recommendations on Treatment of Hepatitis C 2018.
    ;
    J Hepatol; 2018 Aug; 69(2):461-511. PubMed ID: 29650333
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European guideline for the management of hepatitis B and C virus infections, 2010.
    Brook G; Soriano V; Bergin C
    Int J STD AIDS; 2010 Oct; 21(10):669-78. PubMed ID: 21139144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated recommendations for diagnosis and management of the US population for hepatitis C.
    Bragg J
    J Am Osteopath Assoc; 2013 Jun; 113(6):445-6. PubMed ID: 23739753
    [No Abstract]   [Full Text] [Related]  

  • 8. Debilitating fatigue as a treatment indication in chronic hepatitis C.
    Hjerrild S; Dalgard O; Christensen PB; Leutscher P
    J Hepatol; 2015 Dec; 63(6):1533-4. PubMed ID: 26264934
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C".
    Gerber L; Younossi Z
    J Hepatol; 2015 Dec; 63(6):1534-5. PubMed ID: 26375244
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C".
    Pawlotsky JM; Aghemo A; Back D; Dusheiko G; Forns X; Puoti M; Sarrazin C;
    J Hepatol; 2015 Dec; 63(6):1535-6. PubMed ID: 26375242
    [No Abstract]   [Full Text] [Related]  

  • 11. [International consensus conference on hepatitis C. Conclusions. The European Association for the Study of the Liver (EASL) Paris, February 26-28, 1999].
    Gastroenterol Clin Biol; 1999; 23(6-7):730-5. PubMed ID: 10470527
    [No Abstract]   [Full Text] [Related]  

  • 12. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver.
    J Hepatol; 1999 May; 30(5):956-61. PubMed ID: 10365827
    [No Abstract]   [Full Text] [Related]  

  • 13. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement.
    J Hepatol; 1999; 31 Suppl 1():3-8. PubMed ID: 10622553
    [No Abstract]   [Full Text] [Related]  

  • 14. [An introduction of the researches on hepatitis C virus infection from the 46th EASL annual conference].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):412-4. PubMed ID: 22053368
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C screening and evaluation: clinical decision tool.
    Allen JI
    Gastroenterology; 2013 Nov; 145(5):1144-5. PubMed ID: 24139702
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Oklahoma State Department of Health. CDC recommendations for diagnosis and initial management of hepatitis C virus infection.
    Crutcher M; Holt K
    J Okla State Med Assoc; 1999 Feb; 92(2):93-5. PubMed ID: 10024789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations from the National Institutes of Health consensus development conference statement: management of hepatitis C: 2002.
    Hepatology; 2002 Nov; 36(5):1039. PubMed ID: 12395309
    [No Abstract]   [Full Text] [Related]  

  • 18. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement.
    Covic A; Abramowicz D; Bruchfeld A; Leroux-Roels G; Samuel D; van Biesen W; Zoccali C; Zoulim F; Vanholder R;
    Nephrol Dial Transplant; 2009 Mar; 24(3):719-27. PubMed ID: 19202192
    [No Abstract]   [Full Text] [Related]  

  • 19. EASL recommendations on treatment of hepatitis C 2014.
    European Association for the Study of the Liver
    J Hepatol; 2014 Aug; 61(2):373-95. PubMed ID: 24818984
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2283-4. PubMed ID: 17570199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.